Search Results 311-320 of 17037 for colorectal dysplasia
This randomized phase II trial studies how well irinotecan and cetuximab with or without bevacizumab work in treating patients with RAS wild-type colorectal ...
The Colon Cancer Family Registry at Mayo Clinic continues to work with existing study participants on tissue samples and genetic counseling but is not ...
A Study to Evaluate Trifluridine/Tipiracil Combined with Bevacizumab vs Trifluridine/Tipiracil to Treat Patients with Refractory Metastatic Colorectal Cancer.
Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation · Overview · Participation eligibility.
This study will evaluate if the sponge capsule device can accurately detect the presence of Barrett's Esophagus and prevalent dysplasia/adenocarcinoma ...
... dysplasia or colorectal cancer; Subjects with Crohn's Disease (CD) must be in ... Colonic dysplasia within ≤ 5 years prior to Day 0; History of small ...
Methylated DNA Markers for Sporadic Colorectal and Endometrial Cancer Are Strongly Associated with Lynch Syndrome Cancers. Cancer Prev Res (Phila). 2023 Nov 01; ...
His research group discovered a panel of DNA hypermethylation markers to distinguish low-grade anal dysplasia from high-grade dysplasia and anal squamous cell ...
A Study to Evaluate Gevokizumab with Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers · Overview.
About this study. This is a Phase 2, open-label, 2-part, multicenter study in subjects with MSS relapsed/refractory colorectal cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.